NORTHERN NEW ENGLAND CLINICAL ONCOL SOCIETY INC (EIN 020445055) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1990

Legal Domicile

Principal Officer

SHEILA PASCUAL MD

Phone

6038871948

Tax Period

2023-01-01 to 2023-12-31

NORTHERN NEW ENGLAND CLINICAL ONCOL SOCIETY INC, founded in 1990, is a small nonprofit that reported $843K in total revenue in fiscal year 2023. Revenue surged 69% from the prior year, signaling strong growth momentum. The organization ran a surplus of $304K, a strong 36% operating margin.

Mission

THE MISSION OF NNECOS IS TO PROMOTE THE HIGHEST QUALITY CARE FOR PATIENTS WITH CANCER AND BLOOD DISORDERS IN OUR REGION THROUGH PROFESSIONAL NETWORKING, EDUCATION, AND SCIENTIFIC RESEARCH, AS WELL AS PATIENT ADVOCACY AND PUBLIC POLICY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $22,111

Program Service Revenue $783,052

Investment Income $37,422

Other Revenue $0

TOTAL REVENUE $842,585

Expense Breakdown

Grants Paid $19,200

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $519,462

TOTAL EXPENSES $538,662

Year-over-Year Comparison

	2023	2022	Change
Revenue	$842,585	$497,802	+0.7%
Expenses	$538,662	$549,707	0.0%
Net Income	$303,923	$-51,905	-6.9%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
COCAV RAUWERDINK MD LEAVES 102023	IPP - PRESID	5.00	Director	$0	$0	$0
ELIZABETH B MCGRATH DNP AGACNP-BC	A.L.E.C. MEM	2.00	Officer Director	$0	$0	$0
NICHOLAS JENSEN MS LGC	BOARD MEMBER	2.00	Director	$0	$0	$0
KATHLEEN MCBETH MAPSY	BOARD MEMBER	2.00	Director	$0	$0	$0
ALISSA THOMAS MD	BOARD MEMBER	2.00	Director	$0	$0	$0
CARL NELSON MD	IPP - PRESID	5.00	Officer Director	$0	$0	$0
HIBBA TUL REHMAN MD	BOARD MEMBER	2.00	Director	$0	$0	$0
JEANNA WALSH MD	BOARD MEMBER	2.00	Director	$0	$0	$0
JOHN P WINTERS III MD	BOARD MEMBER	2.00	Director	$0	$0	$0
JOHN HILL MD	BOARD MEMBER	2.00	Director	$0	$0	$0
JULIAN SPRAGUE MD	BOARD MEMBER	2.00	Director	$0	$0	$0
KARA LANDRY MD	BOARD MEMBER	2.00	Director	$0	$0	$0
SHEILA PASCUAL MD	PRESIDENT	2.00	Director	$0	$0	$0
YONG LI JI MD	BOARD MEMBER	2.00	Director	$0	$0	$0
NIRAV KAPADIA MD MS	SECRETARY/TR	5.00	Director	$0	$0	$0
EMMA DANN DNP RN OCN NEA-BC	EXEC AT LARG	2.00	Director	$0	$0	$0
BRENDA FARNHAM RN MBA OCN	BOARD MEMBER	2.00	Director	$0	$0	$0
JULIA MOUKHARSKAYA MD PHD	BOARD MEMBER	2.00	Director	$0	$0	$0
SIVAN ROTENBERG PHD	BOARD MEMBER	2.00	Director	$0	$0	$0
MEGAN DEBRA PHARMD	BOARD MEMBER	2.00	Director	$0	$0	$0
YONATAN RESNICK PHARMD	BOARD MEMBER	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$842,585	$538,662	$1,501,042	$303,923
2022	$497,802	$549,707	$1,066,985	$-51,905
2021	$550,488	$366,331	$1,245,751	$184,157
2020	$421,037	$240,870	$1,080,304	$180,167
2019	$486,643	$353,227	$863,054	$133,416
2018	$435,491	$354,807	$666,093	$80,684

NORTHERN NEW ENGLAND CLINICAL ONCOL SOCIETY INC